These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9152999)
21. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors. Reader TA; Molina-Holgado E; Dewar KM Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933 [TBL] [Abstract][Full Text] [Related]
22. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. Hall H; Wedel I Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136 [TBL] [Abstract][Full Text] [Related]
24. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. Leysen JE; Gommeren W J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046 [TBL] [Abstract][Full Text] [Related]
25. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus. Lillrank SM; Lipska BK; Weinberger DR; Fredholm BB; Fuxe K; Ferré S Neurochem Int; 1999 Mar; 34(3):235-44. PubMed ID: 10355490 [TBL] [Abstract][Full Text] [Related]
26. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371 [TBL] [Abstract][Full Text] [Related]
27. Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain. Inoue O; Kobayashi K; Tsukada H; Itoh T; Langstrom B J Neural Transm Gen Sect; 1991; 85(1):1-10. PubMed ID: 1678266 [TBL] [Abstract][Full Text] [Related]
28. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides. Malmberg A; Mohell N J Pharmacol Exp Ther; 1995 Aug; 274(2):790-7. PubMed ID: 7636742 [TBL] [Abstract][Full Text] [Related]
29. Effects of mono- and divalent ions on the binding of the adenosine analogue CGS 21680 to adenosine A2 receptors in rat striatum. Johansson B; Parkinson FE; Fredholm BB Biochem Pharmacol; 1992 Dec; 44(12):2365-70. PubMed ID: 1472101 [TBL] [Abstract][Full Text] [Related]
30. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Hamblin MW; Leff SE; Creese I Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712 [TBL] [Abstract][Full Text] [Related]
31. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex. Gottberg E; Diop L; Montreuil B; Reader TA Neurochem Res; 1989 May; 14(5):419-26. PubMed ID: 2526301 [TBL] [Abstract][Full Text] [Related]
32. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Carli M; Anand-Srivastava MB; Molina-Holgado E; Dewar KM; Reader TA Neurochem Int; 1994 Jan; 24(1):13-22. PubMed ID: 8130731 [TBL] [Abstract][Full Text] [Related]
33. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride. Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137 [TBL] [Abstract][Full Text] [Related]
34. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain. Young LT; Wong DF; Goldman S; Minkin E; Chen C; Matsumura K; Scheffel U; Wagner HN Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131 [TBL] [Abstract][Full Text] [Related]
35. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain. Seeman P; Guan HC; Niznik HB Synapse; 1989; 3(1):96-7. PubMed ID: 2521961 [No Abstract] [Full Text] [Related]
36. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites. Malmberg A; Jerning E; Mohell N Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920 [TBL] [Abstract][Full Text] [Related]
37. Modulation of the serotonin S2-receptor in brain after chronic lithium. Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A Neurochem Res; 1986 Jul; 11(7):949-57. PubMed ID: 2944024 [TBL] [Abstract][Full Text] [Related]
38. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Köhler C; Hall H; Ogren SO; Gawell L Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674 [TBL] [Abstract][Full Text] [Related]
39. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography. Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399 [TBL] [Abstract][Full Text] [Related]
40. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis. Farde L; Eriksson L; Blomquist G; Halldin C J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]